[Apoproteins A1 and B as markers of the severity of cirrhosis].
Since apolipoproteins A1 and B (Apo A1 and Apo B), which are the quantitatively predominant fractions of plasma lipoproteins, are synthetized and/or metabolized in the liver, their variations could represent a significant prognostic factor in patients with cirrhosis. In order to test this theory, the concentrations of Apo A1 and Apo B were measured in 43 patients with confirmed cirrhosis and were found to be reduced. These changes correlated with a number of biochemical tests measuring hepatic function and indicating severe cirrhosis, as well as with a clinico-biological severity index based on these biochemical tests and on the importance of clinical complications during the course of the disease. It is concluded that Apo 1 and Apo B determinations constitute a valuable index of liver synthetizing function.